← back to search

Gary Remington

Dr. Agarwal's Eye Hospital ·
Area of research
Psychiatry and Mental health · Philosophy
Research interest
Research interests include Schizophrenia research and treatment, Mental Health and Psychiatry, Neurotransmitter Receptor Influence on Behavior, and Treatment of Major Depression.
h-index
81
citations
26,397
works
1,556
NIH funding
primary concept
email

Recent publications

Treatment resistance in schizophrenia and depression as an interactive kind: Mapping the development of a classification through Meta-Narrative review
SSM - Mental Health 2024cited by 0position: middledoi
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
Schizophrenia Bulletin 2023cited by 37position: middledoi
Distinct profiles of psychological and neuropsychological functions underlying goal-directed pursuit in schizophrenia
Australian & New Zealand Journal of Psychiatry 2022cited by 0position: middledoi
Treatment Recommendations for Tardive Dyskinesia
The Canadian Journal of Psychiatry 2019cited by 97position: middledoi
The Assessment and Treatment of Antipsychotic-Induced Akathisia
The Canadian Journal of Psychiatry 2018cited by 80position: middledoi
Guidelines for the Pharmacotherapy of Schizophrenia in Adults
The Canadian Journal of Psychiatry 2017cited by 319position: firstdoi
The Effects of Valbenazine in Participants with Tardive Dyskinesia
The Journal of Clinical Psychiatry 2017cited by 87position: middledoi
Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis
Schizophrenia Bulletin 2016cited by 61position: middledoi
Further Neuroimaging Evidence for the Deficit Subtype of Schizophrenia
JAMA Psychiatry 2015cited by 94position: middledoi
Insight and subjective measures of quality of life in chronic schizophrenia
Schizophrenia Research Cognition 2015cited by 61position: lastdoi
2012 CCNP Innovations Award Paper: Antipsychotic dosing: found in translation
Journal of Psychiatry and Neuroscience 2014cited by 14position: firstdoi
Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study
Psychopharmacology 2013cited by 19position: middledoi
Increased Stress-Induced Dopamine Release in Psychosis
Biological Psychiatry 2012cited by 273position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

George Foussias · York University3 papers (2014–2022)Donald Addington · University of Calgary3 papers (2017–2019)Pablo Rusjan · McGill University Health Centre2 papers (2012–2016)Alan Carson · University of Liverpool2 papers (2018–2019) · 2 papers (2018–2019)Ofer Agid · York University2 papers (2014–2015)Sylvain Houle · Centre for Addiction and Mental Health2 papers (2012–2016)Norman Poole · South London and Maudsley NHS Foundation Trust2 papers (2018–2019)Davide Martino · University of Calgary2 papers (2018–2019)Ivonne Suridjan · Roche (Switzerland)2 papers (2012–2016)Mark J. Edwards · King's College London2 papers (2018–2019)Tamara Pringsheim · Allen Institute for Brain Science2 papers (2018–2019)Lucia Ricciardi · St George's, University of London2 papers (2018–2019)David M. Gardner · University of Idaho2 papers (2018–2019)Zahinoor Ismail · University of Calgary2 papers (2013–2017)Romina Mizrahi · McGill University Health Centre2 papers (2012–2016)Thomas R. E. Barnes · Institute for Health Metrics and Evaluation2 papers (2018–2019)Benoit H. Mulsant · Canada Research Chairs2 papers (2013–2015) · 1 papers (2013–2013) · 1 papers (2013–2013)